Table 2 First VTE event (%) stratified by cancer site and timing of event, up to 6 months from discharge

Breast

525,053

4843

0.92

485,009

3643

0.75

525,053

8486

1.62

Lung

395,671

9808

2.48

278,182

6436

2.31

395,671

16,244

4.11

Bowel

432,308

7369

1.70

364,489

5635

1.55

432,308

13,004

3.01

Prostate

384,078

5876

1.53

335,231

2191

0.65

384,078

8067

2.10

Non-Hodgkin lymphoma

134,096

2979

2.22

113,989

2155

1.89

134,096

5134

3.83

Malignant melanoma

86,496

318

0.37

82,445

155

0.19

86,496

473

0.55

Bladder

241,152

2057

0.85

217,217

1547

0.71

241,152

3604

1.49

Kidney

73,273

2229

3.04

60,755

724

1.19

73,273

2953

4.03

Oesophageal

98,668

1395

1.41

79,812

2379

2.98

98,668

3774

3.82

Stomach

86,454

2044

2.36

66,314

1886

2.84

86,454

3930

4.55

Pancreatic

78,579

3846

4.89

52,296

1915

3.66

78,579

5761

7.33

Leukaemia

108,405

1913

1.76

86,648

928

1.07

108,405

2841

2.62

Uterus

74,346

1113

1.50

68,516

705

1.03

74,346

1818

2.45

Ovarian

70,613

2834

4.01

57,162

1314

2.30

70,613

4148

5.87

Oral

69,827

301

0.43

62,784

378

0.60

69,827

679

0.97

Brain

69,362

1545

2.23

55,107

1353

2.46

69,362

2898

4.18

Multiple myeloma

59,610

1058

1.77

48,944

1033

2.11

59,610

2091

3.51

Liver

52,242

2005

3.84

36,485

783

2.15

52,242

2788

5.34

Cervix

33,618

530

1.58

30,596

459

1.50

33,618

989

2.94

Laryngeal

25,918

127

0.49

22,879

86

0.38

25,918

213

0.82

Testicular

22,985

172

0.75

22,481

201

0.89

22,985

373

1.62

Bone/connective tissue

30,023

483

1.61

26,490

293

1.11

30,023

776

2.58

Thyroid

22,718

122

0.54

21,368

56

0.26

22,718

178

0.78

Mesothelioma

22,354

361

1.61

17,350

349

2.01

22,354

710

3.18

Other site

102,771

1792

1.74

87,853

1190

1.35

102,771

2982

2.90

Unknown

258,040

9834

3.81

163,390

4022

2.46

258,040

13,856

5.37

Total

3,558,660

66,954

1.88

2,943,792

41,816

1.42

3,558,660

108,770

3.06